https://orcid.org/0000-0002-5949-6421
References
- Sabater-Molina M, Pérez-Sánchez I, Hernández Del Rincón JP, et al. Genetics of hypertrophic cardiomyopathy: a review of current state. Clin Genet. 2018;93(1):3–14. doi:10.1111/cge.13027
- Gruner C, Ivanov J, Care M, et al. Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2013;6(1):19–26. doi:10.1161/CIRCGENETICS.112.963363
- Ranjbarvaziri S, Kooiker KB, Ellenberger M, et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation. 2021;144(21):1714–1731. doi:10.1161/CIRCULATIONAHA.121.053575
- Lioncino M, Monda E, Caiazza M, et al. Cardiovascular involvement in mtDNA disease: diagnosis, management, and therapeutic options. Heart Fail Clin. 2022;18(1):51–60. doi:10.1016/j.hfc.2021.07.003
- Chinnery PF, Hudson G. Mitochondrial genetics. Br Med Bull. 2013;106(1):135–159. doi:10.1093/bmb/ldt017
- Seneca S, Goemans N, Van Coster R, et al. A mitochondrial tRNA aspartate mutation causing isolated mitochondrial myopathy. Am J Med Genet A. 2005;137(2):170–175. doi:10.1002/ajmg.a.30854
- Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet. 2005;6(5):389–402. doi:10.1038/nrg1606
- Veitia RA. Further quantitative insights into the decrease of heteroplasmy of m.3243A>G with age in leukocytes. Clin Genet. 2019;95(4):542–543. doi:10.1111/cge.13496
- Kuno T, Imaeda S, Asakawa Y, et al. Mitochondrial cardiomyopathy presenting as dilated phase of hypertrophic cardiomyopathy diagnosed with histological and genetic analyses. Case Rep Cardiol. 2017;2017:9473917. doi:10.1155/2017/9473917
- Takeda A, Murayama K, Okazaki Y, et al. Advanced pathological study for definite diagnosis of mitochondrial cardiomyopathy. J Clin Pathol. 2020;206801. doi:10.1136/jclinpath-2020-206801
- Writing Committee Members Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2021;162(1):e23–e106. doi:10.1016/j.jtcvs.2021.04.001
- Chiang S, Kalinowski DS, Jansson PJ, et al. Mitochondrial dysfunction in the neuro-degenerative and cardio-degenerative disease, Friedreich's ataxia. Neurochem Int. 2018;117:35–48. doi:10.1016/j.neuint.2017.08.002
- Sequeira V, Bertero E, Maack C. Energetic drain driving hypertrophic cardiomyopathy. FEBS Lett. 2019;593(13):1616–1626. doi:10.1002/1873-3468.13496
- Kargaran PK, Evans JM, Bodbin SE, et al. Mitochondrial DNA: hotspot for potential gene modifiers regulating hypertrophic cardiomyopathy. J Clin Med. 2020;9(8):2349. doi:10.3390/jcm9082349
- Nollet EE, Duursma I, Rozenbaum A, et al. Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration. Eur Heart J. 2023;44(13):1170–1185. doi:10.1093/eurheartj/ehad028